Delivery Order SPE2DB24D1006-SPE2DB24FCDWP

Award Date 4/18/24
Potential Completion Date 4/19/24
Potential Value $2.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 500 capsules of the prescription drug Ramipril 10 mg, valued at $1,949.35. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,647.77, is for the delivery of 4,558,957,998 units of Ramipril 10 mg capsules, which are a cardiovascular medication. The contract is a Firm Fixed Price Delivery Order that has an ultimate completion date of November 2, 2022. It is not designated with any set-aside requirements, indicating...
This federal contract award is for the delivery of Ramipril 2.5 mg capsules to the Defense Logistics Agency (DLA). The $1,131.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 19, 2022. The contract has a completion date of September 20, 2022 and was not set aside for any specific business category. Amerisourcebergen is a major pharmaceutical distributor that holds two significant Indefinite Delivery Contracts (IDCs) with...
This federal contract award, valued at $2,879.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This delivery order is for 4,563,273,583 units of the medication Ramipril 10 mg capsules, which are used to treat...
This federal contract award is for the delivery of Ramipril 2.5 mg capsules, a cardiovascular medication, to the Defense Logistics Agency (DLA). The contract, valued at $1,894.88, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 30, 2024, with a completion date of January 31, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,387.28 firm fixed-price delivery order is for the supply of 500 capsules of Ramipril 10 mg, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,616.20 firm fixed-price delivery order covers the supply of RAMIPRIL 10 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of February 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FS77A, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,899.68 firm-fixed-price delivery order is for the supply of 4,563,789,849 units of the 10 mg Ramipril capsule medication. The award has an ultimate completion date of February 28, 2024 and was made on February 27, 2024. This contract is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,455.60 delivery order is for the supply of RAMIPRIL 10 MG CAPSULE 100S, which are prescription cardiovascular medications. The contract has an ultimate completion date of August 3, 2021 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,254.44 Firm Fixed Price Delivery Order is for the supply of 4,554,554,561 units of the drug Ramipril 2.5 mg capsules. The contract has an ultimate completion date of August 24, 2021. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA Troop...
  • SPE2DB24D1006
    Indefinite Delivery Contract
  • SPE2DB24D1006-SPE2DB24FCDWP
    Delivery Order

This federal contract award is for the delivery of 4,564,320 units of Ramipril 10 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $2,389.32, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world.

The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. There is no set-aside designation mentioned for this specific delivery order.

Generated 7/18/24, 9:04 AM